Eye and nasal drops 0.03% and 0.06%, 10 ml

Respiratory system. Nasal medications. Anti-congestants and other nasal medications for topical use. Sympathomimetics, combinations, excluding corticosteroids.

ATC code R01AB

• exacerbation of seasonal allergic conjunctivitis;
• exacerbation of year-round allergic conjunctivitis;
• acute rhinitis;
• allergic rhinosinusitis;
• allergic vasomotor rhinitis.

• hypersensitivity to one of the components of the product;
• xerosis of the conjunctiva (dry keratoconjunctivitis, Sjögren's syndrome);
• closed angle glaucoma;
• arterial hypertension, tachycardia, pronounced atherosclerosis;
• diabetes mellitus;
• hypertrophy of the prostate gland;
• hyperthyroidism;
• concomitant use of monoamine oxidase inhibitors and a period of up to 14 days after the end of their use;
• children under 2 years of age (0.03%);
• children under 18 years of age (0.06%);

For rhinitis 0.06% for adults - 2-3 drops in each nasal passage 3 times a day.

For children 0.03% drops:

• 2 to 6 years of age - 1 to 2 drops in each nasal passage 1-2 times a day;
• 6 to 18 years of age - 2 drops in each nasal passage 3 times a day;

The course of treatment is 5-6 days.

For сonjunctivitis:

• Adults 0.06% drops: in acute conditions - 1 drop every 3 hours into conjunctival sac until reduction of edema and eye irritation, then 1 drop 2-3 times/day until clinical symptoms disappear. Children over 2 years of age are prescribed 0.03% 1-2 drops/day. Do not use for more than 5 days. If symptoms of conjunctival irritation persist for more than 72 hours, the product should be discontinued.

Make sure that the tip of the dropper bottle does not come into contact with other objects or surfaces when instilling. Close the dropper bottle tightly with the cap after instillation!

Common:

• burning, itching, eye pain, visual disturbance, hyperemia, conjunctival irritation.

Rare:

• drowsiness, palpitations, hypertension, headaches and dizziness, nausea, increased intraocular pressure.
• The occurrence of systemic reactions or persistent local irritation is an indication to discontinue the product.

Prolonged use may lead to local changes in the epithelium associated with hypoxia (worsening prognosis).

Symptoms: pale skin, tachycardia, heart pain, increased blood pressure, increased sweating, shivering, headache, agitation, nausea, drowsiness, dizziness, prolonged mydriasis.

Treatment: withdrawal of the product, symptomatic treatment.

Use of the product during pregnancy and lactation is possible only when the estimated benefit to the mother exceeds the potential risk to the child and fetus.

Do not use in children under 2 years of age (0.03%).

Wearing soft contact lenses is not recommended when using the product.

Before instillation of eye drops you should remove your hard contact lenses, they can be inserted again at least 15-20 minutes after application of the product.

Effects on ability to drive and use machines

Given the side effects of the product, caution should be exercised when driving motor vehicles or potentially dangerous machinery

10 ml of the product in plastic dropper bottles, sealed with tamper-proof caps, or in plastic dropper bottles, sealed with caps. One bottle is with instruction for use in the state and Russian language are placed in a carton pack.

In a place protected from light, at a temperature below 25˚C.

Keep out of the reach of children.

3 years

After opening the bottle, the period of using the product is 15 days.

"DOSFARM" LLP, 3 Chaplygin street, Almaty city, 050034, Kazakhstan, tel.: (727) 253-03-88.

"DOSFARM" LLP, 3 Chaplygin street, Almaty city, 050034, Kazakhstan.

Name, address, contact information of the organization accepting claims (proposals) against quality of products from consumers in the territory of the Republic of Kazakhstan, which is responsible for post-authorization safety surveillance of the medicine:

"DOSFARM" LLP, 3 Chaplygin street, Almaty city, 050034, Kazakhstan,

Tel./Fax: (727) 253-07-07, 253-03-88, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.